MLH1 c.12G>T ;(p.V4=)

Variant ID: 3-37035050-G-T

NM_000249.3(MLH1):c.12G>T;(p.V4=)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.

Nature Genetics
Körber, Verena V; Stainczyk, Sabine A SA; Kurilov, Roma R; Henrich, Kai-Oliver KO; Hero, Barbara B; Brors, Benedikt B; Westermann, Frank F; Höfer, Thomas T
Publication Date: 2023-03-27

Variant appearance in text: MLH1: V4=
PubMed Link: 36973454
Variant Present in the following documents:
  • 41588_2023_1332_MOESM4_ESM.xlsx, sheet 7
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: MLH1: 12G>T
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699.

British Journal Of Cancer
Daniel, R A RA; Rozanska, A L AL; Mulligan, E A EA; Drew, Y Y; Thomas, H D HD; Castelbuono, D J DJ; Hostomsky, Z Z; Plummer, E R ER; Tweddle, D A DA; Boddy, A V AV; Clifford, S C SC; Curtin, N J NJ
Publication Date: 2010-11-09

Variant appearance in text: MLH-1: V4=
PubMed Link: 20978505
Variant Present in the following documents:
  • Main text
View BVdb publication page